Vitamin D and diabetes mellitus

Hormones

Volumn 13, Issue 2, 2014, Pages 163-181

  Harinarayan, Chittari Venkata ^a  

^a Sakra World Hospital   (India)

Author keywords

Immune functions; Insulin secretion; Insulin sensitivity; Type 1 diabetes mellitus; Type 2 diabetes mellitus; Vitamin D; cell function

Indexed keywords

14 EPIVITAMIN D3 DERIVATIVE; 20 EPICALCITRIOL; ALFACALCIDOL; BETA CASEIN; CALBINDIN; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; CYCLOSPORIN; CYCLOSPORIN A; CYTOCHROME P450; CYTOCHROME P450 C24; ERGOCALCIFEROL; HLA ANTIGEN CLASS 2; INSULIN; LEXACALCITOL; NICOTINAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PLACEBO; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D; YOGHURT; GLUCOSE BLOOD LEVEL;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; B LYMPHOCYTE ACTIVATION; BONE CALCIFICATION; BONE DISEASE; CALCIUM INTAKE; CD4+ T LYMPHOCYTE; COMBINATION CHEMOTHERAPY; CROSS-SECTIONAL STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DIET SUPPLEMENTATION; DIET THERAPY; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; GENETIC RISK; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULITIS; INTERVENTION STUDY; MONOCYTE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLASMACYTOID DENDRITIC CELL; POLYMORPHONUCLEAR CELL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; TISSUE SPECIFICITY; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; METABOLISM; PANCREAS ISLET BETA CELL; PROGNOSIS; RISK FACTOR;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; PROGNOSIS; RISK FACTORS; VITAMIN D;

EID: 84899619939     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401332     Document Type: Review

References (109)

1. Chagas CE, Borges MC, Martini LA, Rogero MM, 2012 Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4: 52-67.
2. IDF diabetes atlas. International Diabetes Federation 2009 Available at: http://www.idf.org/diabetesatlas/5e/ the-global-burden last accessed on 30/09/2012.
3. Reichrath J, 2007 Exp Dermatol 16: 618-625.
4. Holick MF, 2004 Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362-371.
5. Webb AR, Kline L, Holick MF, 1988 Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67: 373-378.
6. Bikle DD, Pillai S, Gee E, Hincenbergs M, 1985 Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 124: 655-660.
7. Ohyama Y, Ozono K, Uchida M, et al, 1996 Functional assessment of two vitamin D-responsive elements in the rat 25-hydroxyvitamin D3 24-hydroxylase gene. J Biol Chem 271: 30381-30385.
8. DeLuca HF, 2004 Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80: Suppl 6: 1689-1696.
9. McKenna NJ, Lanz RB, O'Malley BW, 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20: 321-344.
10. Razani B, Woodman SE, Lisanti MP, 2002 Caveolae: from cell biology to animal physiology. Pharmacol Rev 54: 431-467.
11. Prosser DE, Jones G, 2004 Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29: 664-673.
12. Takiishi T, Gysemans C, Bouillon R, Mathieu C, 2010 Vitamin D and diabetes. Endocrinol Metab Clin North Am 39: 419-446.
13. Bikle DD, 2009 Extra renal synthesis of 1,25 dihydroxy vitamin D and its health implications. Clin Rev Bone Miner Metab 7: 114-125.
14. Nishimura A, Shinki T, Jin CH, et al, 1994 Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts. Endocrinology 134: 794-1799.
15. Schauber J, Dorschner RA, Coda AB, et al, 2007 Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117: 803-811.
16. Nagpal S, Na S, Rathnachalam R, 2005 Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687.
17. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE, 2007 Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179: 1634-1647.
18. Bikle DD, 2009 Vitamin D and immune function: Understanding common pathways. Curr Osteoporos Rep 7: 58-63.
19. Tanaka H, Abe E, Miyaura C, Shiina Y, Suda T, 1983 1-alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun 117: 86-92.
20. Liu PT, Stenger S, Li H, et al, 2006 Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
21. Liu YJ, 2005 IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306.
22. Guery JC, Adorini L, 1995 Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol 154: 536-544.
23. Schwartz RH, 1990 A cell culture model for T lymphocyte clonal anergy. Science 248: 1349-1356.
24. Penna G, Adorini L, 2000 1-Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164: 2405-2411.
25. Sadeghi K, Wessner B, Laggner U, et al, 2006 Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36: 361-371.
26. van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO, 2004 1-alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23: 233-239.
27. Griffin MD, Lutz WH, Phan VA, et al, 2000 Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem Biophys Res Commun 270: 701-708.
28. Lemire JM, Adams JS, Sakai R, Jordan SC, 1984 1-alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74: 657-661.
29. Mathieu C, Badenhoop K, 2005 Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab 16: 261-266.
30. Spach KM, Nashold FE, Dittel BN, Hayes CE, 2006 IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177: 6030-6037.
31. Iho S, Iwamoto K, Kura F, Okuno Y, Takahashi T, Hoshino T, 1990 Mechanism in 1,25(OH)2D3-induced suppression of helper/suppressor function of CD4/CD8 cells to immunoglobulin production in B cells. Cell Immunol 127: 12-25.
32. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A, 2001 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(1) T cells to enhance the development of Th2 cells. J Immunol 167: 4974-4980.
33. Imazeki I, Matsuzaki J, Tsuji K, Nishimura T, 2006 Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res 27: 1-9.
34. van Etten E, Mathieu C, 2005 Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97: 93-101.
35. Overbergh L, Decallonne B, Waer M, et al, 2009 1alpha,25-dihydroxyvitamin D3 induces an autoantigen specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49: 1301-1307.
36. Korn T, Oukka M, Kuchroo V, Bettelli E, 2007 Th17 cells: effector T cells with inflammatory properties. Semin Immunol 19: 362-371.
37. Atkinson MA, Maclaren NK, 1995 The pathogenesis of insulin-dependent diabetes mellitus. Engl J Med 331: 1428-1436.
38. Foulis AK, McGill M, Farquharson MA, 1991 Insulitis in type 1 (insulin-dependent) diabetes mellitus in man--macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol 165: 97-103.
39. Riachy R, Vandewalle B, Belaich S, et al, 2001 Beneficial effect of 1,25 dihydroxyvitamin D3 on cytokine-treated human pancreatic islets. J Endocrinol 169: 161-168.
40. Mauricio D, Mandrup-Poulsen T, Nerup J, 1996 Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective. Diabetes Metab Rev 12: 57-68.
41. Eizirik DL, Cardozo AK, Cnop M, 2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29: 42-61.
42. Hahn HJ, Kuttler B, Mathieu C, Bouillon R, 1997 1,25-Dihydroxyvitamin D3 reduces MHC antigen expression on pancreatic beta-cells in vitro. Transplant Proc 29: 2156-2157.
43. Riachy R, Vandewalle B, Moerman E, et al, 2006 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor. Apoptosis 11:151-159.
44. Mohr SB, Garland CF, Gorham ED, Garland FC, 2008 The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51: 1391-1398.
45. Casteels K, Waer M, Laureys J, et al, 1998 Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Diabetes 51: 1367-1374.
46. Del Pino-Montes J, Benito GE, Fernandez-Salazar MP, et al, 2004 Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcif Tissue Int 75: 526-532.
47. Casteels K, Waer M, Laureys J, et al, 1998 Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation 65: 1225-1232.
48. Zipitis CS, Akobeng AK, 2008 Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93: 512-517.
49. Vitamin D supplementation in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group 1999 Diabetologia 42: 51-54.
50. EURODIAB ACE Study Group, 2000 Variation and trends in incidence of childhood diabetes in Europe. Lancet 355: 873-876.
51. Lorini R, Minicucci L, Napoli F, et al, 2005 Screening for type 1 diabetes genetic risk in newborns of continental Italy. Primary prevention (Prevefin Italy)--preliminary data. Acta Biomed 76(Suppl 3): 31-35.
52. Li X, Liao L, Yan X, et al, 2009 Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes. (LADA). Diabetes Metab Res Rev 25: 411-416.
53. Brekke HK, Ludvigsson J, 2007 Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr Diabetes 8: 11-14.
54. Bock G, Prietl B, Mader JK, et al, 2011 The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev 27: 942-945.
55. Gabbay MA, Sato MN, Finazzo C, Duarte AJ, Dib SA, 2012 Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med 166: 601-607.
56. Aljabri KS, Bokhari SA, Khan MJ, 2010 Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med 30: 454-458.
57. Bizzarri C, Pitocco D, Napoli N, IMDIAB Group, et al, 2010 No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XII trial. Diabetes Care 33: 1962-1963.
58. Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG, 2010 No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 33: 1443-1448.
59. Pitocco D, Crinò A, Di Stasio E, IMDIA B Group, et al, 2006 The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet Med 23: 920-923.
60. Norman AW, 2006 Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 147: 5542-5548.
61. Eliades M, Pittas AG, 2010 Vitamin D and type 2 diabetes. In Vitamin D Physiology, Molecular Biology and clinical applications ed. Holick M F. Humana press: pp, 895-920.
62. Fujita T, Palmieri GM, 2000 Calcium paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 18: 109-125.
63. Fujita T, 2000 Calcium paradox: consequences of calcium deficiency manifested by a wide variety of diseases. J Bone Miner Metab 18: 234-236.
64. Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C, 2005 The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol 349: 248-260.
65. Wei Y, Sowers JR, Clark S. E, Li W, Ferrario CM, Stump CS, 2008 Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase. Am J Physiol Endocrinol Metab 294: E345-351.
66. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L, 2002 1alpha,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51: 1367-1374.
67. Chertow BS, Sivitz WI, Baranetsky NG, Cordle MB, DeLuca HF, 1986 Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats. Diabetes 35: 771-775.
68. Cade C, Norman AW, 1987 Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120: 1490-1497.
69. Norman AW, Frankel JB, Heldt AM, Grodsky GM, 1980 Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823-825.
70. Pittas AG, Lau J, Hu FB, Dawson-Hughes B, 2007 The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029.
71. Martins D, Wolf M, Pan D, et al, 2007 Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167: 1159-1165.
72. Scragg R, Sowers M, Bell C, 2004 Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27: 2813-2818.
73. Hyppönen E, Boucher BJ, Berry DJ, Power C, 2008 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 57: 298-305.
74. Chiu KC, Chu A, Go VL, Saad MF, 2004 Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79: 820-825.
75. Alvarez J. A, Ashraf A, 2010 Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010: 351-385.
76. Need AG, O'Loughlin PD, Horowitz M, Nordin BE, 2005 Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women. Clin Endocrinol (Oxf) 62: 738-741.
77. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM, 2005 Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28: 2926-2932.
78. Pittas AG, Dawson-Hughes B, Li T, et al, 2006 Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29: 650-656.
79. Knekt P, Laaksonen M, Mattila C, et al, 2008 Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19: 666-671.
80. Harris SS, Pittas AG, Palermo NJ, 2012 A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 14: 789-794.
81. Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, et al, 2011 Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr 20: 521-526.
82. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG, 2011 Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94: 486-494.
83. Nikooyeh B, Neyestani TR, Farvid M, et al, 2011 Daily consumption of vitamin D-or vitamin D + calciumfortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93: 764-771.
84. Sabherwal S, Bravis V, Devendra D, 2010 Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int J Clin Pract 64: 1084-1089.
85. von Hurst PR, Stonehouse W, Coad J, 2010 Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomized, placebocontrolled trial. Br J Nutr 103: 549-555.
86. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B, 2007 The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 30: 980-986.
87. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R, 2003 The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57: 258-261.
88. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ, 1995 Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 38: 1239-1245.
89. Orwoll E, Riddle M, Prince M, 1994 Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 59: 1083-1087.
90. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T, 1986 Effect of 1α(OH)-vitaminD3 on insulin secretion in diabetes mellitus. Bone Miner 1: 187-192.
91. Gedik O, Akalin S, 1986 Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29: 142-145.
92. Nyomba BL, Auwerx J, Bormans V, 1986 Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia 29: 34-38.
93. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD, 2010 The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53: 2112-2119.
94. Jorde R, Sneve M, Torjesen P, Figenschau Y, 2010 No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern 267: 462-472.
95. Patel P, Poretsky L, Liao E, 2010 Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial. J Diabetes 2: 36-40.
96. Parekh D, Sarathi V, Shivane VK, Bandgar TR, Menon PS, Shah NS, 2010 Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr Pract 16: 600-608.
97. Avenell A, Cook JA, Maclennan GS, Macpherson GC, RECORD trial group, 2009 Vitamin D supplementation and type 2 diabetes: a substudy of a randomized placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 38: 606-609.
98. Jorde R, Figenschau Y, 2009 Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48: 349-354.
99. Nagpal J, Pande JN, Bhartia A, 2009 A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26: 19-27.
100. Zittermann A, Frisch S, Berthold HK, et al, 2009 Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89: 1321-1327.
101. de Boer IH, Tinker LF, Connelly S, et al, 2008 Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 31: 701-707.
102. Tai K, Need AG, Horowitz M, Chapman IM, 2008 Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 24: 950-956.
103. Sugden JA, Davies JI, Witham MD, et al, 2008 Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med 25: 320-325.
104. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E, 1997 No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 27: 629-633.
105. Zofková I, Stolba P, 1990 Effect of calcitriol and trifluoperazine on glucose stimulated B cell function in healthy humans. Exp Clin Endocrinol 95: 185-191.
106. Lind L, Pollare T, Hvarfner A, Lithell H, Sørensen OH, Ljunghall S, 1989 Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 11: 141-147.
107. Ljunghall S, Lind L, Lithell H, et al, 1987 Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance. A prospective randomized double-blind study. Acta Med Scand 222: 361-367.
108. Nilas L, Christiansen C, 1984 Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes 8: 407-411.
109. Harinarayan CV, Arvind S, Joshi S, Thennarasu K, Vedavyas V, Baindur A, 2014 Improvement in Pancreatic β Cell Function with Vitamin D and Calcium Supplementation in Vitamin D Deficient Non-Diabetic Subjects. Endocr Pract 20: 129-137.